201 related articles for article (PubMed ID: 15030392)
1. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
[TBL] [Abstract][Full Text] [Related]
2. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.
Thomas AG; Bodner A; Ghadge G; Roos RP; Slusher BS
J Neurovirol; 2009 Sep; 15(5-6):449-57. PubMed ID: 19995130
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration.
Berent-Spillson A; Russell JW
J Neurochem; 2007 Apr; 101(2):342-54. PubMed ID: 17402968
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor regulation of neuronal cell death.
Spillson AB; Russell JW
Exp Neurol; 2003 Nov; 184 Suppl 1():S97-105. PubMed ID: 14597332
[TBL] [Abstract][Full Text] [Related]
6. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
[TBL] [Abstract][Full Text] [Related]
8. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
[TBL] [Abstract][Full Text] [Related]
11. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Cai Z; Lin S; Rhodes PG
Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
[TBL] [Abstract][Full Text] [Related]
13. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.
Carpenter KJ; Sen S; Matthews EA; Flatters SL; Wozniak KM; Slusher BS; Dickenson AH
Neuropeptides; 2003 Oct; 37(5):298-306. PubMed ID: 14607107
[TBL] [Abstract][Full Text] [Related]
14. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
15. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
Urazaev AK; Grossfeld RM; Lieberman EM
J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
[TBL] [Abstract][Full Text] [Related]
19. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]